tradingkey.logo

tradingkey.logo
怜玢


Gelteq Ltd

GELS
りォッチリストに远加
0.436USD
-0.015-3.43%
終倀 05/15, 16:00ET15分遅れの株䟡
4.67M時䟡総額
損倱額盎近12ヶ月PER

詳现チャヌトを衚瀺
Intraday
1m
30m
1h
D
W
M
D

本日

-3.43%

5日間

-7.28%

1ヶ月

-37.74%

6ヶ月

-56.33%

幎初来

-45.52%

1幎間

-77.18%

TradingKey 株匏スコア

デヌタが䞍十分なため、株匏スコアは利甚できたせん。

Gelteq Ltd ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Gelteq Ltdの䌁業情報

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
䌁業コヌドGELS
䌁業名Gelteq Ltd
最高経営責任者「CEO」Givoni (Nathan Jacob)
りェブサむトhttps://www.gelteq.com
KeyAI
î™